Info@ThinkPinkRocks.com

RNF43 mutation may serve as biomarker that identifies colorectal, endometrial cancer patients

Scientists say they have identified in about 20 percent of colorectal and endometrial cancers a genetic mutation that had been overlooked in recent large, comprehensive gene searches. With this discovery, the altered gene, called RNF43, now ranks as one of the most common mutations in the two cancer types.

Continued here:
RNF43 mutation may serve as biomarker that identifies colorectal, endometrial cancer patients

Share

Leave a Reply